These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 28970046)

  • 1. AAV8 Can Induce Innate and Adaptive Immune Response in the Primate Eye.
    Reichel FF; Dauletbekov DL; Klein R; Peters T; Ochakovski GA; Seitz IP; Wilhelm B; Ueffing M; Biel M; Wissinger B; Michalakis S; Bartz-Schmidt KU; Fischer MD;
    Mol Ther; 2017 Dec; 25(12):2648-2660. PubMed ID: 28970046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity to adeno-associated virus vectors in animals and humans: a continued challenge.
    Zaiss AK; Muruve DA
    Gene Ther; 2008 Jun; 15(11):808-16. PubMed ID: 18385765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term retinal cone rescue using a capsid mutant AAV8 vector in a mouse model of CNGA3-achromatopsia.
    Dai X; He Y; Zhang H; Zhang Y; Liu Y; Wang M; Chen H; Pang JJ
    PLoS One; 2017; 12(11):e0188032. PubMed ID: 29131863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to circumvent humoral immunity to adeno-associated viral vectors.
    Tse LV; Moller-Tank S; Asokan A
    Expert Opin Biol Ther; 2015 Jun; 15(6):845-55. PubMed ID: 25985812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral Immune Response After Intravitreal But Not After Subretinal AAV8 in Primates and Patients.
    Reichel FF; Peters T; Wilhelm B; Biel M; Ueffing M; Wissinger B; Bartz-Schmidt KU; Klein R; Michalakis S; Fischer MD;
    Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):1910-1915. PubMed ID: 29677353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges Posed by Immune Responses to AAV Vectors: Addressing Root Causes.
    Hamilton BA; Wright JF
    Front Immunol; 2021; 12():675897. PubMed ID: 34084173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer.
    Costa Verdera H; Kuranda K; Mingozzi F
    Mol Ther; 2020 Mar; 28(3):723-746. PubMed ID: 31972133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-existing anti-adeno-associated virus antibodies as a challenge in AAV gene therapy.
    Louis Jeune V; Joergensen JA; Hajjar RJ; Weber T
    Hum Gene Ther Methods; 2013 Apr; 24(2):59-67. PubMed ID: 23442094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adeno-associated virus (AAV) vectors in gene therapy: immune challenges and strategies to circumvent them.
    Hareendran S; Balakrishnan B; Sen D; Kumar S; Srivastava A; Jayandharan GR
    Rev Med Virol; 2013 Nov; 23(6):399-413. PubMed ID: 24023004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Innate immune mechanisms against recombinant adeno-associated virus vectors--a review].
    Diao Y; Xu R
    Wei Sheng Wu Xue Bao; 2012 May; 52(5):550-7. PubMed ID: 22803339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.
    Li Q; Miller R; Han PY; Pang J; Dinculescu A; Chiodo V; Hauswirth WW
    Mol Vis; 2008 Sep; 14():1760-9. PubMed ID: 18836574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Developments in gene delivery vectors for ocular gene therapy].
    Khabou H; Dalkara D
    Med Sci (Paris); 2015 May; 31(5):529-37. PubMed ID: 26059304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Dose and Safety of AAV7m8 and AAV8BP2 in the Non-Human Primate Retina.
    Ramachandran PS; Lee V; Wei Z; Song JY; Casal G; Cronin T; Willett K; Huckfeldt R; Morgan JI; Aleman TS; Maguire AM; Bennett J
    Hum Gene Ther; 2017 Feb; 28(2):154-167. PubMed ID: 27750461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming innate immune barriers that impede AAV gene therapy vectors.
    Muhuri M; Maeda Y; Ma H; Ram S; Fitzgerald KA; Tai PW; Gao G
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33393506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adeno-associated Virus (AAV) versus Immune Response.
    Rabinowitz J; Chan YK; Samulski RJ
    Viruses; 2019 Jan; 11(2):. PubMed ID: 30691064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AAV8-mediated hepatic gene transfer in infant rhesus monkeys (Macaca mulatta).
    Wang L; Bell P; Lin J; Calcedo R; Tarantal AF; Wilson JM
    Mol Ther; 2011 Nov; 19(11):2012-20. PubMed ID: 21811248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vector decoys trick the immune response.
    VandenDriessche T; Chuah MK
    Sci Transl Med; 2013 Jul; 5(194):194fs28. PubMed ID: 23863831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5
    Majowicz A; Salas D; Zabaleta N; Rodríguez-Garcia E; González-Aseguinolaza G; Petry H; Ferreira V
    Mol Ther; 2017 Aug; 25(8):1831-1842. PubMed ID: 28596114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host Immune Responses after Suprachoroidal Delivery of AAV8 in Nonhuman Primate Eyes.
    Chung SH; Mollhoff IN; Mishra A; Sin TN; Ngo T; Ciulla T; Sieving P; Thomasy SM; Yiu G
    Hum Gene Ther; 2021 Jul; 32(13-14):682-693. PubMed ID: 33446041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Intravitreal AAV-Mediated Inner Retinal Gene Transduction after Surgical Internal Limiting Membrane Peeling in Cynomolgus Monkeys.
    Takahashi K; Igarashi T; Miyake K; Kobayashi M; Yaguchi C; Iijima O; Yamazaki Y; Katakai Y; Miyake N; Kameya S; Shimada T; Takahashi H; Okada T
    Mol Ther; 2017 Jan; 25(1):296-302. PubMed ID: 28129123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.